105 / 150
We propose to perform an educational intervention targeting both
primary and secondary care settings. We will then re-audit to assess
the efficacy of our intervention.
ID: 5086
Intersectoral collaboration surrounding patients in need of
infection control measures
–
how do we do it?
Bente Bloch.
Hospital of Southern Jutland
Background:
Today the patient care in hospitals is highly specialised
and undertaken at high speed. Many patients receive complex
treatment and care, which often continues in the primary sector,
when the patient is discharged.
Aim(s)/Objective(s):
The aim of the study was to investigate and
analyse the intersectoral collaboration, to gain a better understanding
of the collaboration across health sectors in relation to the patient in
need of treatment/care where infection control plays an important
role.
Method(s):
The study is a qualitative, multiple case study, where semi
structured interviews form the base of the empirical knowledge used.
The theory behind the study is the perspective on intersectoral
collaboration, examples of models of collaboration and the strength
and weaknesses of collaboration.
Results:
The study showed that the motivational factors for inter-
sectoral collaboration were: focus on organisation and structure in
the organisations, collaboration through networks, awareness of the
importance of clear communications paths and focus on the
professional competencies in relation to infection hygiene. A struc-
tured collaboration with the establishment of an actual infection
control organisation resulted in access to expert knowledge, security
among the personnel as well as motivation to work with infection
control as an area of focus.
Discussion and/or Conclusion(s):
Nosocomial infections in patients
transferring from one health sector to another can likely be prevented
by the introduction of knowledge of infection control to all levels of
personnel in the sectors, and by entering into a formalised collabor-
ation across the health sectors with the aim of establishing an
intersectoral infection control organization.
ID: 5091
Is the use of Octenidine wash the answer to zero acquisition of
Health-Care Associated Methicillin Resistant Staphylococcus
aureus (MRSA) bacteraemia?
Marietta Niala, Rohinton Mulla, Sue Fox.
Luton and Dunstable
University Hospital NHS Foundation Trust
Background:
Every year, Trusts in the National Health Service are
given certain Health Care associated infection targets to meet and
MRSA bacteraemia is one of them.
Aim(s)/Objective(s):
The aim of the audit was to determine if the use
of Octenidine Hydrochloride wash as prophylactic body wash had
made an impact on the zero acquisition target of Health Care
Associated MRSA bacteraemia for a year.
Method(s):
Since September 2015, Octenidine Hydrochloride body-
wash was introduced as a prophylactic body wash in the care of the
elderly wards and as part of an MRSA admission decolonisation
treatment on previous MRSA positive patients.
A trust wide audit was carried out from September 2014-August 2015
and September 2015-August 2016 to assess the effectiveness of the
prophylactic body wash.
Results:
A total of 239 patients were identified as MRSA positive in
September 2014-August 2015 while 117 patients were identified as
MRSA positive in September 2015-August 2016 following the
introduction of prophylactic Octenidine Hydrochloride on patients
admitted in the Care of the ElderlyWards and as part of decolonisation
admission treatment in patients previously MRSA positive. Since the
introduction of the prophylactic bodywash and the decolonisation
admission treatment in the previous MRSA positive patients, there has
been no further Health Care Associated MRSA bacteraemia.
Discussion and/or Conclusion(s):
The introduction of Octenidine
Hydrochloride bodywash has made a significant impact in MRSA
general acquisition and to the zero acquisition target of Health Care
Associated MRSA bacteraemia in a District General Hospital.
ID: 5103
Use of ICNet for clinical microbiology record keeping
Rosemary Fok
1
, Cressida Auckland
2
.
1
Derriford Hospital, Plymouth
Hospitals NHS Trust,
2
Royal Devon and Exeter NHS Foundation Trust
Background:
Keeping clear clinical records is a necessity. Finding the
optimum method for recording clinical microbiology advice and
interaction with other healthcare professionals can be challenging,
especially if there is no electronic patient record or consultations take
place over the phone and away from the paper medical records.
Bespoke electronic solutions are often costly to implement. We trialled
the use of existing infection control surveillance software for the
keeping of clinical microbiology records.
Aim(s)/Objective(s):
To trial the use of ICNet for clinical microbiology
record keeping.
Method(s):
ICNet infection control surveillance software was already
in use in the trust. We worked with ICNet to develop aspects of the
software to suit our clinical microbiology record keeping needs. We
replaced our existing method of record keeping with ICNet.
ID: 5124
Leptospirosis serological testing and clinical features: a
retrospective Scottish single-centre study
Clark Russell
1
, Michael E. Jones
2
, Daire T. O
’
Shea
3
, Kenneth J. Simpson
4
,
Ian F. Laurenson
5
.
1
NHS Lothian,
2
HealthLink360, Musselburgh,
3
Regional
Infectious Diseases Unit, Western General Hospital, Edinburgh,
4
Scottish
Liver Transplantation Unit, Royal Infirmary of Edinburgh, Edinburgh,
5
Clinical Microbiology, Laboratory Medicine, Royal Infirmary of
Edinburgh, Edinburgh, UK
Background:
Leptospirosis is a zoonotic infection occurring world-
wide but is endemic in tropical countries. The clinical presentation is
heterogeneous, ranging from an undifferentiated febrile illness to
‘
Weil
’
s disease
’
. Serological testing is the main diagnostic modality.
Aim(s)/Objective(s):
To review serological testing for Leptospirosis at
our institution over a 10-year period and describe the clinical features
of cases.
Method(s):
We identified patients from two tertiary care hospitals in
Edinburgh, United Kingdom, who had samples sent to a Public
Health England reference laboratory for Leptospirosis testing between
2006
–
2016. Clinical, laboratory and microbiological information on
cases was collected retrospectively. Complete details were unavailable
for four cases.
Results:
480 samples were sent for Leptospirosis IgM ELISA testing:
450 were negative, 26 were positive and four were equivocal.
There was no temporal trend to testing. The positive results came
from 14 patients with a median age of 26 years. Nine cases were
imported, mostly from Asia and with a history of fresh water exposure.
Patients presented with non-specific symptoms: fever (10/11);
myalgia (8/11); gastrointestinal symptoms (8/11); and headache
(7/11). Laboratory evidence of hepatitis (8/10), acute kidney injury
(5/10) and lymphopenia (8/10) was common. One patient developed
‘
Weil
’
s disease
’
with multi-organ failure. Antimicrobials were admi-
nistered in seven cases, usually doxycycline (5/7). There were no
deaths.
Discussion and/or Conclusion(s):
Leptospirosis is an uncommon
infection in Scotland. Most cases are imported, in contrast to recent
UK-wide data, and this may be attributable to the Scottish climate. The
clinical presentation is protean and mild hepato-renal involvement
is common even in the absence of organ failure.
Abstracts of FIS/HIS 2016
–
Poster Presentations / Journal of Hospital Infection 94S1 (2016) S24
–
S134
S100